
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Thermostable vaccines: an innovative concept in vaccine development
Ravinder Kumar, Vartika Srivastava, Piyush Baindara, et al.
Expert Review of Vaccines (2022) Vol. 21, Iss. 6, pp. 811-824
Closed Access | Times Cited: 37
Ravinder Kumar, Vartika Srivastava, Piyush Baindara, et al.
Expert Review of Vaccines (2022) Vol. 21, Iss. 6, pp. 811-824
Closed Access | Times Cited: 37
Showing 1-25 of 37 citing articles:
Influenza and Universal Vaccine Research in China
Jiali Li, Yifan Zhang, Xinglong Zhang, et al.
Viruses (2022) Vol. 15, Iss. 1, pp. 116-116
Open Access | Times Cited: 39
Jiali Li, Yifan Zhang, Xinglong Zhang, et al.
Viruses (2022) Vol. 15, Iss. 1, pp. 116-116
Open Access | Times Cited: 39
Yeast-Based Virus-like Particles as an Emerging Platform for Vaccine Development and Delivery
Vartika Srivastava, Kripa N. Nand, Aijaz Ahmad, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 479-479
Open Access | Times Cited: 27
Vartika Srivastava, Kripa N. Nand, Aijaz Ahmad, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 479-479
Open Access | Times Cited: 27
Oral Vaccines: A Better Future of Immunization
Keith Wai-Yeung Kwong, Ying Xin, Nelson Cheuk-Yin Lai, et al.
Vaccines (2023) Vol. 11, Iss. 7, pp. 1232-1232
Open Access | Times Cited: 27
Keith Wai-Yeung Kwong, Ying Xin, Nelson Cheuk-Yin Lai, et al.
Vaccines (2023) Vol. 11, Iss. 7, pp. 1232-1232
Open Access | Times Cited: 27
Microneedles: An Emerging Vaccine Delivery Tool and a Prospective Solution to the Challenges of SARS-CoV-2 Mass Vaccination
Yaxiu Feng, Huan Hu, Yu-Yuen Wong, et al.
Pharmaceutics (2023) Vol. 15, Iss. 5, pp. 1349-1349
Open Access | Times Cited: 19
Yaxiu Feng, Huan Hu, Yu-Yuen Wong, et al.
Pharmaceutics (2023) Vol. 15, Iss. 5, pp. 1349-1349
Open Access | Times Cited: 19
Application of anti-fungal vaccines as a tool against emerging anti-fungal resistance
Ravinder Kumar, Vartika Srivastava
Frontiers in Fungal Biology (2023) Vol. 4
Open Access | Times Cited: 15
Ravinder Kumar, Vartika Srivastava
Frontiers in Fungal Biology (2023) Vol. 4
Open Access | Times Cited: 15
Clinical and Preclinical Methods of Heat-Stabilization of Human Vaccines
Grace L. Williamson, Eric M. Bachelder, Kristy M. Ainslie
Molecular Pharmaceutics (2024) Vol. 21, Iss. 3, pp. 1015-1026
Closed Access | Times Cited: 5
Grace L. Williamson, Eric M. Bachelder, Kristy M. Ainslie
Molecular Pharmaceutics (2024) Vol. 21, Iss. 3, pp. 1015-1026
Closed Access | Times Cited: 5
Role of artificial intelligence in early diagnosis and treatment of infectious diseases
Vartika Srivastava, Ravinder Kumar, Mohmmad Younus Wani, et al.
Infectious Diseases (2024), pp. 1-26
Closed Access | Times Cited: 4
Vartika Srivastava, Ravinder Kumar, Mohmmad Younus Wani, et al.
Infectious Diseases (2024), pp. 1-26
Closed Access | Times Cited: 4
Synthetic and Biogenic Materials for Oral Delivery of Biologics: From Bench to Bedside
Suwan Ding, Elena Alexander, Huiyi Liang, et al.
Chemical Reviews (2025)
Closed Access
Suwan Ding, Elena Alexander, Huiyi Liang, et al.
Chemical Reviews (2025)
Closed Access
Detoxification Techniques for Bacterial Toxins: A Pathway to Effective Toxoid Vaccines
Parvaneh Esmaeilnejad-Ahranjani, Youcef Shahali, Maryam Dadar
Toxicon (2025) Vol. 260, pp. 108365-108365
Closed Access
Parvaneh Esmaeilnejad-Ahranjani, Youcef Shahali, Maryam Dadar
Toxicon (2025) Vol. 260, pp. 108365-108365
Closed Access
Efficiency of Chitosan Nanocarriers in Vaccinology for Mucosal Immunization
Salvatore Calogero Gaglio, Massimiliano Perduca, Donato Zipeto, et al.
Vaccines (2023) Vol. 11, Iss. 8, pp. 1333-1333
Open Access | Times Cited: 10
Salvatore Calogero Gaglio, Massimiliano Perduca, Donato Zipeto, et al.
Vaccines (2023) Vol. 11, Iss. 8, pp. 1333-1333
Open Access | Times Cited: 10
Biomineralization-inspired synthesis of autologous cancer vaccines for personalized metallo-immunotherapy
Quguang Li, Yifan Yan, Chunjie Wang, et al.
iScience (2024) Vol. 27, Iss. 7, pp. 110189-110189
Open Access | Times Cited: 3
Quguang Li, Yifan Yan, Chunjie Wang, et al.
iScience (2024) Vol. 27, Iss. 7, pp. 110189-110189
Open Access | Times Cited: 3
Effectiveness of a community-centered Newcastle disease vaccine delivery model under paid and free vaccination frameworks in southeastern Kenya
Kennedy O. Ogolla, Douglas N. Anyona, Judith K. Chemuliti, et al.
PLoS ONE (2024) Vol. 19, Iss. 8, pp. e0308088-e0308088
Open Access | Times Cited: 3
Kennedy O. Ogolla, Douglas N. Anyona, Judith K. Chemuliti, et al.
PLoS ONE (2024) Vol. 19, Iss. 8, pp. e0308088-e0308088
Open Access | Times Cited: 3
Mitigating the effects of climate change on human health with vaccines and vaccinations
Cara Lynn Kim, Suneth Agampodi, Florian Marks, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 7
Cara Lynn Kim, Suneth Agampodi, Florian Marks, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 7
A poly(amidoamine)-based polymeric nanoparticle platform for efficient in vivo delivery of mRNA
Adriano P. Pontes, Steffen van der Wal, Karin Roelofs, et al.
Biomaterials Advances (2023) Vol. 156, pp. 213713-213713
Open Access | Times Cited: 7
Adriano P. Pontes, Steffen van der Wal, Karin Roelofs, et al.
Biomaterials Advances (2023) Vol. 156, pp. 213713-213713
Open Access | Times Cited: 7
The Two Sides of the COVID-19 Pandemic
Ravinder Kumar, Vartika Srivastava, Kripa N. Nand
COVID (2023) Vol. 3, Iss. 12, pp. 1746-1760
Open Access | Times Cited: 7
Ravinder Kumar, Vartika Srivastava, Kripa N. Nand
COVID (2023) Vol. 3, Iss. 12, pp. 1746-1760
Open Access | Times Cited: 7
Frost Fighters: Unveiling the Potentials of Microbial Antifreeze Proteins in Biotech Innovation
Joana Camila Lopes, Camila Tomazini Kinasz, Alanna Maylle Cararo Luiz, et al.
Journal of Applied Microbiology (2024) Vol. 135, Iss. 6
Open Access | Times Cited: 2
Joana Camila Lopes, Camila Tomazini Kinasz, Alanna Maylle Cararo Luiz, et al.
Journal of Applied Microbiology (2024) Vol. 135, Iss. 6
Open Access | Times Cited: 2
A Thermal-Stable Protein Nanoparticle That Stimulates Long Lasting Humoral Immune Response
Ten‐Tsao Wong, Gunn‐Guang Liou, Ming-Chung Kan
Vaccines (2023) Vol. 11, Iss. 2, pp. 426-426
Open Access | Times Cited: 6
Ten‐Tsao Wong, Gunn‐Guang Liou, Ming-Chung Kan
Vaccines (2023) Vol. 11, Iss. 2, pp. 426-426
Open Access | Times Cited: 6
RNA Vaccines: Yeast as a Novel Antigen Vehicle
Anna Jéssica Duarte Silva, Mylenna Máyra Gois de Sousa, Larissa Silva de Macêdo, et al.
Vaccines (2023) Vol. 11, Iss. 8, pp. 1334-1334
Open Access | Times Cited: 6
Anna Jéssica Duarte Silva, Mylenna Máyra Gois de Sousa, Larissa Silva de Macêdo, et al.
Vaccines (2023) Vol. 11, Iss. 8, pp. 1334-1334
Open Access | Times Cited: 6
Freeze-Drying of a Capsid Virus-like Particle-Based Platform Allows Stable Storage of Vaccines at Ambient Temperature
Kara-Lee Aves, Christoph M. Janitzek, Cyrielle Fougeroux, et al.
Pharmaceutics (2022) Vol. 14, Iss. 6, pp. 1301-1301
Open Access | Times Cited: 9
Kara-Lee Aves, Christoph M. Janitzek, Cyrielle Fougeroux, et al.
Pharmaceutics (2022) Vol. 14, Iss. 6, pp. 1301-1301
Open Access | Times Cited: 9
Standardization and Key Aspects of the Development of Whole Yeast Cell Vaccines
Anna Jéssica Duarte Silva, Crislaine Kelly da Silva Rocha, Antônio Carlos de Freitas
Pharmaceutics (2022) Vol. 14, Iss. 12, pp. 2792-2792
Open Access | Times Cited: 9
Anna Jéssica Duarte Silva, Crislaine Kelly da Silva Rocha, Antônio Carlos de Freitas
Pharmaceutics (2022) Vol. 14, Iss. 12, pp. 2792-2792
Open Access | Times Cited: 9
Practical Considerations for Next-Generation Adjuvant Development and Translation
William R. Lykins, Christopher B. Fox
Pharmaceutics (2023) Vol. 15, Iss. 7, pp. 1850-1850
Open Access | Times Cited: 5
William R. Lykins, Christopher B. Fox
Pharmaceutics (2023) Vol. 15, Iss. 7, pp. 1850-1850
Open Access | Times Cited: 5
Influenza H7N9 Virus Hemagglutinin with T169A Mutation Possesses Enhanced Thermostability and Provides Effective Immune Protection against Lethal H7N9 Virus Challenge in Chickens
Libin Chen, Dexin Kong, Xiaolong Hu, et al.
Vaccines (2023) Vol. 11, Iss. 8, pp. 1318-1318
Open Access | Times Cited: 4
Libin Chen, Dexin Kong, Xiaolong Hu, et al.
Vaccines (2023) Vol. 11, Iss. 8, pp. 1318-1318
Open Access | Times Cited: 4
Cancer/Testis Antigens as Targets for RNA-Based Anticancer Therapy
Kyeonghee Shim, Hyein Jo, Dooil Jeoung
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14679-14679
Open Access | Times Cited: 4
Kyeonghee Shim, Hyein Jo, Dooil Jeoung
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14679-14679
Open Access | Times Cited: 4
Thermostable bivalent filovirus vaccine protects against severe and lethal Sudan ebolavirus and marburgvirus infection
Albert To, Teri Ann S. Wong, Aquena H. Ball, et al.
Vaccine (2023) Vol. 42, Iss. 3, pp. 598-607
Closed Access | Times Cited: 4
Albert To, Teri Ann S. Wong, Aquena H. Ball, et al.
Vaccine (2023) Vol. 42, Iss. 3, pp. 598-607
Closed Access | Times Cited: 4
Duckweeds as edible vaccines in the animal farming industry
Anca Awal Sembada, Yohanes Theda, Ahmad Faizal
3 Biotech (2024) Vol. 14, Iss. 10
Closed Access | Times Cited: 1
Anca Awal Sembada, Yohanes Theda, Ahmad Faizal
3 Biotech (2024) Vol. 14, Iss. 10
Closed Access | Times Cited: 1